Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease.

Ganesh, Swaytha

Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease. [electronic resource] - Clinics in liver disease May 2016 - 351-64 p. digital

Publication Type: Journal Article; Review

1557-8224

10.1016/j.cld.2015.10.009 doi


Angiotensin Receptor Antagonists--therapeutic use
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Anti-Obesity Agents--therapeutic use
Anticholesteremic Agents--therapeutic use
Antioxidants--therapeutic use
Cannabinoid Receptor Antagonists--therapeutic use
Cholagogues and Choleretics--therapeutic use
Fatty Acids, Omega-3--therapeutic use
Humans
Hypoglycemic Agents--therapeutic use
Insulin Resistance
Lactones--therapeutic use
Metformin--therapeutic use
Non-alcoholic Fatty Liver Disease--drug therapy
Orlistat
Pentoxifylline--therapeutic use
Piperidines--therapeutic use
Probiotics--therapeutic use
Pyrazoles--therapeutic use
Rimonabant
Synbiotics
Thiazolidinediones--therapeutic use
Ursodeoxycholic Acid--therapeutic use
Vitamin E--therapeutic use
Glucagon-Like Peptide-1 Receptor Agonists